Groundbreaking ‘Gnocchi’ map reveals hidden secrets of the human genome

Study presents a genome-wide map, “Gnocchi,” constructed from 76,156 human genomes, revealing that non-coding regions rich in regulatory elements are crucial in understanding human traits and diseases.

Biomea’s early-stage diabetes drug put on full clinical hold, stock crashes

Biomea Fusion’s Phase 1/2 covalent menin inhibitor program in diabetes has been placed on full clinical hold due to “possible” drug-related hepatotoxicity. Liver enzyme elevations

June 8, 2024

ADC terminates Phase II trial for lymphoma therapy – Pharmaceutical Technology

Sobi has exclusive rights for marketing Zynlonta in the EU and other international markets, except the US, Greater China, Singapore, and Japan. Image Credit: meeboonstudio

July 21, 2023

Cambridge launches program to tackle engineered pandemic risks

Covid-19 showed us how vulnerable the world is to pandemics – but what if the next pandemic were somehow engineered? How would the world respond

February 28, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.